Previous close | 0.1454 |
Open | 0.1563 |
Bid | 0.0000 x 0 |
Ask | 0.1451 x 100 |
Day's range | 0.1440 - 0.1563 |
52-week range | 0.1440 - 1.1600 |
Volume | |
Avg. volume | 510,409 |
Market cap | 22.921M |
Beta (5Y monthly) | 1.22 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.4400 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.75 |
SAN DIEGO, March 20, 2024--Cue Health Inc. ("Cue" or the "Company") (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the "Board") to best position the Company for its next stage:
Cue Health Inc. (NASDAQ:HLTH) Q4 2023 Earnings Call Transcript March 13, 2024 Cue Health Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.45. HLTH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for […]
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 28.89% and 6.81%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?